- Home
- KTTA vs MTNB Comparison
KTTA vs MTNB Comparison
Compare KTTA & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KTTA
- MTNB
- Stock Information
- Founded
- KTTA 2020
- MTNB 2013
- Country
- KTTA United States
- MTNB United States
- Employees
- KTTA N/A
- MTNB N/A
- Industry
- KTTA Biotechnology: Pharmaceutical Preparations
- MTNB Biotechnology: Pharmaceutical Preparations
- Sector
- KTTA Health Care
- MTNB Health Care
- Exchange
- KTTA Nasdaq
- MTNB Nasdaq
- Market Cap
- KTTA 5.1M
- MTNB 5.2M
- IPO Year
- KTTA 2021
- MTNB N/A
- Fundamental
- Price
- KTTA $0.68
- MTNB $1.13
- Analyst Decision
- KTTA
- MTNB Hold
- Analyst Count
- KTTA 0
- MTNB 1
- Target Price
- KTTA N/A
- MTNB N/A
- AVG Volume (30 Days)
- KTTA 119.6K
- MTNB 72.2K
- Earning Date
- KTTA 08-19-2025
- MTNB 08-18-2025
- Dividend Yield
- KTTA N/A
- MTNB N/A
- EPS Growth
- KTTA N/A
- MTNB N/A
- EPS
- KTTA N/A
- MTNB N/A
- Revenue
- KTTA N/A
- MTNB N/A
- Revenue This Year
- KTTA N/A
- MTNB N/A
- Revenue Next Year
- KTTA N/A
- MTNB N/A
- P/E Ratio
- KTTA N/A
- MTNB N/A
- Revenue Growth
- KTTA N/A
- MTNB N/A
- 52 Week Low
- KTTA $0.65
- MTNB $0.47
- 52 Week High
- KTTA $7.50
- MTNB $8.39
- Technical
- Relative Strength Index (RSI)
- KTTA 38.79
- MTNB 67.59
- Support Level
- KTTA $0.67
- MTNB $0.84
- Resistance Level
- KTTA $0.79
- MTNB $1.08
- Average True Range (ATR)
- KTTA 0.04
- MTNB 0.08
- MACD
- KTTA 0.00
- MTNB 0.01
- Stochastic Oscillator
- KTTA 23.70
- MTNB 100.00
About KTTA Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).
About MTNB Matinas Biopharma Holdings Inc.
Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others.